Mutual of America Capital Management’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SRDX
TI
SCM
DGI
RA
Mutual of America Capital Management's SRDX Position: Q4 2022 in Review
Mutual of America Capital Management sold out of Surmodics (SRDX) in Q4 2022, closing a stake of 2,787 shares — an estimated $85K sold.
Mutual of America Capital Management first reported a position in SRDX in Q2 2018 and held it in 18 quarters. The position peaked at $107K in Q2 2021. 121 funds tracked by Wall St. Rank hold SRDX as of Q4 2022.
- Mutual of America Capital Management reported no remaining Surmodics position as of Q4 2022 after selling out during the quarter.
- Mutual of America Capital Management sold 2,787 Surmodics shares in Q4 2022, an estimated $85K.
- Mutual of America Capital Management first reported a position in Surmodics in Q2 2018 and held it in 18 quarters.
- Mutual of America Capital Management's Surmodics position peaked at $107K in Q2 2021.
- 121 funds tracked by Wall St. Rank held Surmodics as of Q4 2022.
Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.